ENVESTNET ASSET MANAGEMENT INC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 153 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$948,000
-22.5%
135,226
+1.5%
0.00%0.0%
Q2 2021$1,224,000
-1.4%
133,280
+4.3%
0.00%0.0%
Q1 2021$1,242,000
+467.1%
127,762
+498.8%
0.00%
Q4 2020$219,000
+3.3%
21,338
+1.7%
0.00%
Q3 2020$212,000
-2.3%
20,978
+1.0%
0.00%
Q2 2020$217,000
+16.7%
20,761
-5.9%
0.00%
Q1 2020$186,000
+86.0%
22,057
+92.8%
0.00%
Q4 2019$100,000
-17.4%
11,438
+2.0%
0.00%
Q3 2019$121,000
-52.4%
11,219
+71.6%
0.00%
Q1 2019$254,000
+2209.1%
6,536
+3340.0%
0.00%
Q2 2018$11,000
-15.4%
190
-4.0%
0.00%
Q1 2018$13,000
-7.1%
198
+38.5%
0.00%
Q4 2017$14,000
+27.3%
143
+52.1%
0.00%
Q3 2017$11,000
-77.1%
94
-94.2%
0.00%
Q2 2016$48,0000.0%1,613
-0.6%
0.00%
Q1 2016$48,000
-48.9%
1,623
+34.9%
0.00%
Q4 2015$94,000
-14.5%
1,203
-17.8%
0.00%
-100.0%
Q3 2015$110,000
+10900.0%
1,463
+29160.0%
0.00%
Q3 2014$1,0000.0%5
-37.5%
0.00%
Q2 2014$1,0000.0%80.0%0.00%
Q1 2014$1,00080.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2016
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders